Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
Natalia Baran(The University of Texas MD Anderson Cancer Center), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), Anna Skwarska(Albert Einstein College of Medicine), Ken Furudate(The University of Texas MD Anderson Cancer Center), Anne Marinier(Institute for Research in Immunology and Cancer), Katayoun Rezvani(The University of Texas MD Anderson Cancer Center), Vivian Ruvolo(Hormel (United States)), Mathieu Tremblay(Institute for Research in Immunology and Cancer), Shelley M. Herbrich(The University of Texas MD Anderson Cancer Center), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Adolfo A. Ferrando(Regeneron (United States)), Meghan Collins(The University of Texas at Austin), David T. Teachey(Children's Hospital of Philadelphia), Gheath Alatrash(Mayo Clinic), Di Du(The University of Texas MD Anderson Cancer Center), Marc O. Warmoes(The University of Texas MD Anderson Cancer Center), Guy Sauvageau(Institute for Research in Immunology and Cancer), Helen Ma(Columbia University Irving Medical Center), Shanti Rojas-Sutterin(Institute for Research in Immunology and Cancer), Elias Jabbour(The University of Texas MD Anderson Cancer Center), André Haman(Institute for Research in Immunology and Cancer), Koichi Takahashi(The University of Texas MD Anderson Cancer Center), Renu Pandey(The University of Texas at Austin), Jun J. Yang(St. Jude Children's Research Hospital), Mihai Gagea(The University of Texas MD Anderson Cancer Center), Fieke W. Hoff(University Medical Center Groningen), Yogesh Dhungana(St. Jude Children's Research Hospital), R. Eric Davis(The University of Texas MD Anderson Cancer Center), May Daher(The University of Texas MD Anderson Cancer Center), Karine G. Harutyunyan(Baylor College of Medicine), Terzah M. Horton(Unknown), Vinitha M. Kuruvilla(The University of Texas MD Anderson Cancer Center), Shannon Sweeney(The University of Texas at Austin), Diogo F. T. Veiga(Universidade Estadual de Campinas (UNICAMP)), Ningping Feng(The University of Texas MD Anderson Cancer Center), Antonio Cavazos(The University of Texas MD Anderson Cancer Center), Shraddha Patel(The University of Texas MD Anderson Cancer Center), Mecit Kaplan(The University of Texas MD Anderson Cancer Center), Katarzyna Tomczak(Postgraduate School of Molecular Medicine), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Sriram S. Shanmugavelandy(AbbVie (United States)), Daniel Herranz(Spanish National Cancer Research Centre), Sujan Piya(The University of Texas MD Anderson Cancer Center), Marcin M. Kamiński(St. Jude Children's Research Hospital), Yves Gareau(Merck Canada Inc. (Canada)), Alessia Lodi(The University of Texas at Austin), Wentao Yang(St. Jude Children's Research Hospital), Maria Emilia Di Francesco(The University of Texas MD Anderson Cancer Center), Jason Gay(The University of Texas MD Anderson Cancer Center), Luciana Melo Garcia(Université Laval)
Cited by 63
Related Papers
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
|Współczesna Onkologia|2015|3.5k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k